VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - TSX:VHI - CA92847V5018 - Common Stock
11.03 CAD
-0.53 (-4.58%)
Overall VHI gets a fundamental rating of 6 out of 10. We evaluated VHI against 9 industry peers in the Health Care Technology industry. VHI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. VHI is growing strongly while it is still valued neutral. This is a good combination! With these ratings, VHI could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year VHI was profitable.
VHI had a positive operating cash flow in the past year.
In multiple years VHI reported negative net income over the last 5 years.
VHI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 1.79%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
VHI has a better Return On Equity (2.71%) than 100.00% of its industry peers.
VHI has a Return On Invested Capital of 3.20%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VHI is in line with the industry average of 3.20%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.79% | ||
| ROE | 2.71% | ||
| ROIC | 3.2% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of VHI (5.99%) is better than 100.00% of its industry peers.
With an excellent Operating Margin value of 12.27%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
VHI's Operating Margin has improved in the last couple of years.
VHI has a Gross Margin of 80.89%. This is amongst the best in the industry. VHI outperforms 88.89% of its industry peers.
VHI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.27% | ||
| PM (TTM) | 5.99% | ||
| GM | 80.89% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for VHI has been increased compared to 1 year ago.
Compared to 5 years ago, VHI has more shares outstanding
Compared to 1 year ago, VHI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.05 indicates that VHI is not in any danger for bankruptcy at the moment.
VHI has a Altman-Z score of 5.05. This is in the better half of the industry: VHI outperforms 66.67% of its industry peers.
The Debt to FCF ratio of VHI is 1.16, which is an excellent value as it means it would take VHI, only 1.16 years of fcf income to pay off all of its debts.
VHI has a Debt to FCF ratio of 1.16. This is amongst the best in the industry. VHI outperforms 88.89% of its industry peers.
VHI has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
VHI's Debt to Equity ratio of 0.08 is fine compared to the rest of the industry. VHI outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.16 | ||
| Altman-Z | 5.05 |
ROIC/WACC0.35
WACC9.04%
2.3 Liquidity
VHI has a Current Ratio of 1.59. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
VHI has a better Current ratio (1.59) than 77.78% of its industry peers.
VHI has a Quick Ratio of 1.59. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
VHI has a better Quick ratio (1.59) than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.59 |
3. Growth
3.1 Past
VHI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.00%.
VHI shows a strong growth in Revenue. In the last year, the Revenue has grown by 41.68%.
Measured over the past years, VHI shows a very strong growth in Revenue. The Revenue has been growing by 46.32% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)41.68%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%46.93%
3.2 Future
VHI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 82.60% yearly.
Based on estimates for the next years, VHI will show a very strong growth in Revenue. The Revenue will grow by 27.28% on average per year.
EPS Next Y67.73%
EPS Next 2Y111.49%
EPS Next 3Y82.6%
EPS Next 5YN/A
Revenue Next Year53.53%
Revenue Next 2Y36.13%
Revenue Next 3Y27.28%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 110.30, VHI can be considered very expensive at the moment.
Based on the Price/Earnings ratio, VHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
VHI is valuated expensively when we compare the Price/Earnings ratio to 26.76, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 35.23, VHI can be considered very expensive at the moment.
VHI's Price/Forward Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 88.89% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.63. VHI is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 110.3 | ||
| Fwd PE | 35.23 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 100.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 88.89% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 51.69 | ||
| EV/EBITDA | 34.41 |
4.3 Compensation for Growth
VHI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of VHI may justify a higher PE ratio.
A more expensive valuation may be justified as VHI's earnings are expected to grow with 82.60% in the coming years.
PEG (NY)1.63
PEG (5Y)N/A
EPS Next 2Y111.49%
EPS Next 3Y82.6%
5. Dividend
5.1 Amount
No dividends for VHI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (10/29/2025, 7:00:00 PM)
11.03
-0.53 (-4.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners28.48%
Inst Owner ChangeN/A
Ins Owners11.46%
Ins Owner ChangeN/A
Market Cap694.89M
Revenue(TTM)82.63M
Net Income(TTM)4.95M
Analysts81.43
Price Target15.78 (43.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-41.3%
Min EPS beat(2)-54.3%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-35.59%
Min EPS beat(4)-54.3%
Max EPS beat(4)-25.74%
EPS beat(8)1
Avg EPS beat(8)-29.95%
EPS beat(12)1
Avg EPS beat(12)-44.36%
EPS beat(16)2
Avg EPS beat(16)-71.47%
Revenue beat(2)2
Avg Revenue beat(2)3.92%
Min Revenue beat(2)0.61%
Max Revenue beat(2)7.24%
Revenue beat(4)3
Avg Revenue beat(4)2.93%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)7.24%
Revenue beat(8)6
Avg Revenue beat(8)3.43%
Revenue beat(12)9
Avg Revenue beat(12)2.84%
Revenue beat(16)12
Avg Revenue beat(16)3.4%
PT rev (1m)-0.34%
PT rev (3m)5.31%
EPS NQ rev (1m)25%
EPS NQ rev (3m)-10.01%
EPS NY rev (1m)0%
EPS NY rev (3m)-46.81%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)5.03%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)17.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 110.3 | ||
| Fwd PE | 35.23 | ||
| P/S | 8.41 | ||
| P/FCF | 51.69 | ||
| P/OCF | 48.85 | ||
| P/B | 3.81 | ||
| P/tB | 22.35 | ||
| EV/EBITDA | 34.41 |
EPS(TTM)0.1
EY0.91%
EPS(NY)0.31
Fwd EY2.84%
FCF(TTM)0.21
FCFY1.93%
OCF(TTM)0.23
OCFY2.05%
SpS1.31
BVpS2.89
TBVpS0.49
PEG (NY)1.63
PEG (5Y)N/A
Graham Number2.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.79% | ||
| ROE | 2.71% | ||
| ROCE | 5.04% | ||
| ROIC | 3.2% | ||
| ROICexc | 5.66% | ||
| ROICexgc | N/A | ||
| OM | 12.27% | ||
| PM (TTM) | 5.99% | ||
| GM | 80.89% | ||
| FCFM | 16.27% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.16 | ||
| Debt/EBITDA | 0.87 | ||
| Cap/Depr | 10.65% | ||
| Cap/Sales | 0.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.38% | ||
| Profit Quality | 271.64% | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.59 | ||
| Altman-Z | 5.05 |
F-Score3
WACC9.04%
ROIC/WACC0.35
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next Y67.73%
EPS Next 2Y111.49%
EPS Next 3Y82.6%
EPS Next 5YN/A
Revenue 1Y (TTM)41.68%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%46.93%
Revenue Next Year53.53%
Revenue Next 2Y36.13%
Revenue Next 3Y27.28%
Revenue Next 5YN/A
EBIT growth 1Y23.46%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year69.12%
EBIT Next 3Y40.69%
EBIT Next 5YN/A
FCF growth 1Y81.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.62%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
Can you provide the valuation status for VITALHUB CORP?
ChartMill assigns a valuation rating of 6 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
What are the PE and PB ratios of VITALHUB CORP (VHI.CA) stock?
The Price/Earnings (PE) ratio for VITALHUB CORP (VHI.CA) is 110.3 and the Price/Book (PB) ratio is 3.81.